Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity
John R. Power, Charles Dolladille, Adriel Procureur, Stéphane Éderhy, Nicolas L. Palaskas, Lorenz Lehmann, Jennifer Cautela, Pierre‐Yves Courand, Salim S. Hayek, Han Zhu, Vlad G. Zaha, Richard K. Cheng, Joachim Alexandre, François Roubille, Lauren A. Baldassarre, Alan H. Baik, Michal Laufer‐Perl, Yuichi Tamura, Aarti Asnani, Sanjeev Francis, Elizabeth Gaughan, Peter P. Rainer, Guillaume Bailly, Danette Flint, Dimitri Arangalage, Eve Cariou, Roberta Florido, Anna Narezkina, Yan Liu, Shahneen Sandhu, Darryl Leong, N. Issa, Nicolas Piriou, Lucie Heinzerling, Giovanni Peretto, Shanthini M. Crusz, Nausheen Akhter, Joshua Levenson, Isik Turker, Assié Eslami, Charlotte Fenioux, Pedro Moliner, Michel Obéid, Wei‐Ting Chang, Stephen M Ewer, Seyed Ebrahim Kassaian, Douglas B. Johnson, Anju Nohria, Osnat Itzhaki Ben Zadok, Javid J. Moslehi, Joe‐Elie Salem (2024). Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity. , DOI: https://doi.org/10.1101/2024.06.02.24308336.
